Mitsubishi UFJ Asset Management
JUNO

Mitsubishi UFJ Asset Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,916
Closed -$92K – 857
2017
Q4 		$92K Sell
1,916
-65
-3% -$3.24K ﹤0.01% 790
2017
Q3 		$89K Sell
1,981
-67
-3% -$2.28K ﹤0.01% 789
2017
Q2 		$61K Sell
2,048
-127
-6% -$3.13K ﹤0.01% 806
2017
Q1 		$48K Sell
2,175
-208
-9% -$4.46K ﹤0.01% 815
2016
Q4 		$46K Sell
2,383
-68
-3% -$1.66K ﹤0.01% 809
2016
Q3 		$74K Buy
2,451
+221
+10% +$6.88K ﹤0.01% 782
2016
Q2 		$86K Sell
2,230
-125
-5% -$5.19K ﹤0.01% 781
2016
Q1 		$90K Buy
+2,355
New +$82.1K ﹤0.01% 779

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Mitsubishi UFJ Asset Management's JUNO Position: Q1 2018 in Review

Mitsubishi UFJ Asset Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 1,916 shares — an estimated $92K sold.

Mitsubishi UFJ Asset Management first reported a position in JUNO in Q1 2016 and held it in 8 quarters. The position peaked at $92K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Mitsubishi UFJ Asset Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 1,916 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $92K.
  • Mitsubishi UFJ Asset Management first reported a position in Juno Therapeutics, Inc. in Q1 2016 and held it in 8 quarters.
  • Mitsubishi UFJ Asset Management's Juno Therapeutics, Inc. position peaked at $92K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2018, filed 2 May 2018.